Perfluorohexyloctane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease (DED)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This study will evaluate the efficacy, safety and tolerability of perfluorohexyloctane (NOV03) at two different dosing regimens compared to saline solution in subjects with Dry Eye Disease (DED).
Epistemonikos ID: 250b3f0792686c195c45aa958db434ac06c34802
First added on: May 21, 2024